Pegfilgrastim: the promise of pegylation fulfilled
- PMID: 12488286
- DOI: 10.1093/annonc/mdg036
Pegfilgrastim: the promise of pegylation fulfilled
Comment in
-
A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy.Ann Oncol. 2003 Jan;14(1):29-35. doi: 10.1093/annonc/mdg019. Ann Oncol. 2003. PMID: 12488289 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
